subject: Trends In Clinical Trials In India [print this page] Clinical trials are a huge and booming sector of the Indian healthcare industry. The rise in its development owing to enhanced education systems and medical architecture and information technology sector is driving India to become a clinical trial hub. There are new medical companies and CRO (clinical research organizations) that are commencing their operations in India and are conducting clinical trials on new products for instance stem cells, nanotechnology based products, Biotech products and many more. The government regulations concerning clinical trials too are becoming more rigid and are going to make the approval process more simplified.
The 21st century has ushered in various upcoming domains in the healthcare industry. It has witnessed the clinical trial industry getting into an alliance with the IT industry that is helping it to become the biggest profit making industry round the globe. It is the only industry that has survived amidst the global meltdown. This is very evident from the business that has been generated back in 2009 of approximately 250 300 billions. The forces that have been driving behind this progress are the human quest for better medical treatment and knowledge.
Apart from this, in the past few years the expense of inventing new drugs has been rising because of the global inflation and has increased from $ 802 million in 2003 to about $1.2 billion in 2010. Owing to this heavy expense companies around the globe are witnessing more on the development of existing drugs with fresh dosage forms. In 2011 Norman Goldfarb conducted a quarterly review of the clinical trial industry and asserted that the industry is moving towards a bright future with numerous medical companies foraying into the medical sector.
From the regulatory services perspective, conducting clinical trials needs certain sanctions and approvals. Owing to the developing medical scenario today might become a little complex a clinical research organization or researcher to comply with all the regulation and guidelines. It is also similar to the situation of enrolling and locating the subjects for trials. The Central Drug Standard Control Organization (CDSCO) has released a new guidance concerning clinical trial approvals and new the drugs in 2011. Therefore, regulatory services in India are becoming more stringent as per the bioethics principles.
Furthermore, there are fresh technologies on which medical research is being carried on that comprises transgenic animals, protein chips, stem cells, Bioinformatics, biometrics, medical devices, functional genomics, Pharmacogenomics, molecular modeling, Chemoinformatics, proteomics, protein modeling and many more.
